3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is growing attracting clinical attention due to limited information suggesting unique pharmacological actions. Current analyses suggest that 3-HPC may display separate effects on the brain system, arguably playing a role to some of the unexplained reactions related with PCP exposu